MAATH ALANI: Open Payments
NPI 1518250133 · ALLEN PARK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 35 payments from 7 companies in 2025. Trend: 2023 $288 · 2024 $299 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $388 |
| E.R. Squibb & Sons, L.L.C. | 9 | $143 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Novo Nordisk Inc | 1 | $30 |
| Lundbeck LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: AIRSUPRA, ELIQUIS, TRELEGY ELLIPTA, BREZTRI, INGREZZA, Ozempic, REXULTI, CAPLYTA.
Industry payments across MI — which companies pay providers there.
